Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Jennison

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|February 14, 2012
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpointsMartin Jenkins, Andrew Stone, Christopher Jennison
Statistical Methods in Medical Research|September 18, 2014
A multi-stage drop-the-losers design for multi-arm clinical trialsJames Wason, Nigel Stallard, Jack Bowden, et al.
Pharmaceutical Statistics|October 6, 2015
Model free audit methodology for bias evaluation of tumour progression in oncologyAndrew Stone, Euan Macpherson, Ann Smith, et al.
Statistics in Medicine|June 13, 2025
Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A TutorialCorine Baayen, Paul Blanche, Christopher Jennison, et al.
Biometrical Journal. Biometrische Zeitschrift|June 8, 2018
Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significanceHuiling Li, Jianming Wang, Xiaolong Luo, et al.
Biometrics|June 8, 2017
A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looksAjit C Tamhane, Jiangtao Gou, Christopher Jennison, et al.
Journal of Biopharmaceutical Statistics|March 11, 2017
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?Tom Parke, Olga Marchenko, Vladimir Anisimov, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 8, 2017
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort StudyPeter Eibich, Amelia Green, Andrew T Hattersley, et al.
Trials|July 14, 2025
Clinical trials with interim analyses: standardizing terminology to increase clarityElina Asikanius, Benjamin Hofner, Lisa V Hampson, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|February 14, 2012
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpointsMartin Jenkins, Andrew Stone, Christopher Jennison
Statistical Methods in Medical Research|September 18, 2014
A multi-stage drop-the-losers design for multi-arm clinical trialsJames Wason, Nigel Stallard, Jack Bowden, et al.
Pharmaceutical Statistics|October 6, 2015
Model free audit methodology for bias evaluation of tumour progression in oncologyAndrew Stone, Euan Macpherson, Ann Smith, et al.
Statistics in Medicine|June 13, 2025
Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A TutorialCorine Baayen, Paul Blanche, Christopher Jennison, et al.
Biometrical Journal. Biometrische Zeitschrift|June 8, 2018
Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significanceHuiling Li, Jianming Wang, Xiaolong Luo, et al.
Biometrics|June 8, 2017
A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looksAjit C Tamhane, Jiangtao Gou, Christopher Jennison, et al.
Journal of Biopharmaceutical Statistics|March 11, 2017
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?Tom Parke, Olga Marchenko, Vladimir Anisimov, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 8, 2017
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort StudyPeter Eibich, Amelia Green, Andrew T Hattersley, et al.
Trials|July 14, 2025
Clinical trials with interim analyses: standardizing terminology to increase clarityElina Asikanius, Benjamin Hofner, Lisa V Hampson, et al.
Pageof 3